Net profit of Novartis India declined 4.22% to Rs 25.45 crore in the quarter ended December 2024 as against Rs 26.57 crore during the previous quarter ended December 2023. Sales rose 10.01% to Rs 93.00 crore in the quarter ended December 2024 as against Rs 84.54 crore during the previous quarter ended December 2023. ParticularsQuarter EndedDec. 2024Dec. 2023% Var. Sales93.0084.54 10 OPM %27.5123.39 - PBDT35.8241.57 -14 PBT35.2941.31 -15 NP25.4526.57 -4 Powered by Capital Market - Live News

Novartis India will hold a meeting of the Board of Directors of the Company on 28 January 2025.Powered by Capital Market - Live News

Net profit of Novartis India declined 13.81% to Rs 20.41 crore in the quarter ended September 2024 as against Rs 23.68 crore during the previous quarter ended September 2023. Sales rose 10.60% to Rs 87.11 crore in the quarter ended September 2024 as against Rs 78.76 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales87.1178.76 11 OPM %20.6321.47 - PBDT28.1533.08 -15 PBT27.5632.43 -15 NP20.4123.68 -14 Powered by Capital Market - Live News

Novartis India will hold a meeting of the Board of Directors of the Company on 25 October 2024.Powered by Capital Market - Live News

Net profit of Novartis India rose 27.05% to Rs 25.74 crore in the quarter ended June 2024 as against Rs 20.26 crore during the previous quarter ended June 2023. Sales rose 1.87% to Rs 92.29 crore in the quarter ended June 2024 as against Rs 90.60 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales92.2990.60 2 OPM %25.9719.17 - PBDT34.2329.33 17 PBT33.6827.77 21 NP25.7420.26 27 Powered by Capital Market - Live News